People | February 18, 2022
Lyra Therapeutics appoints Harlan W. Waksal as Executive Chairman
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
Hitz shall assume new role from January 17th, 2022
He has over 22 years of experience in pharmaceutical sales & business development
Subscribe To Our Newsletter & Stay Updated
